ArticleClinical pharmacology and therapeutics2020
Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases.
Abstract read
In one paragraph
Article in Clinical pharmacology and therapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Analytical Validation of NETest2.0Cancers · 2026Article
- Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based Circulating Tumor DNA Assays, Version 2.0.JCO precision oncology · 2026Article
- Circulating Tumor DNA in Ovarian Cancer: Emerging Roles in Early Detection, Risk Stratification, and Disease Monitoring.Cancers · 2026Review
- Prevention of Gastric Cancer.Medicina (Kaunas, Lithuania) · 2026Review
- Generic Protocols for Analytical Validation of Tumor-Informed Circulating Tumor DNA Assays for Molecular Residual Disease: The Blood Profiling Atlas in Cancer's Molecular Residual Disease Analytical Validation Working Group Consensus Recommendation.JCO precision oncology · 2026Article
- BLOODPAC's collaborations with European Union liquid biopsy initiatives.The journal of liquid biopsy · 2025Article
- Next-Generation Sequencing for Bloodstream Infections: Shaping the Future of Rapid Diagnostics and Precision Medicine.Diagnostics (Basel, Switzerland) · 2025Review
- Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium.Neuro-oncology · 2025Review
- Variability of Circulating Tumor DNA Levels in Plasma Samples From Patients With Advanced Non-Small-Cell Lung Cancer in the Absence of Treatment.JCO precision oncology · 2025Article
- Shining the Path of Precision Diagnostic: Advancements in Photonic Sensors for Liquid Biopsy.Biosensors · 2025Review
- Subpar reporting of pre-analytical variables in RNA-focused blood plasma studies.Molecular oncology · 2025Review
- Minimum Technical Preanalytical, Patient, and Clinical Context Data Elements for Cerebrospinal Fluid Liquid Biopsy: Recommendations for Public Database Submissions.JCO precision oncology · 2025Article
- Modulating cell-free DNA biology as the next frontier in liquid biopsies.Trends in cell biology · 2025Review
- Liquid Biopsy: The Challenges of a Revolutionary Approach in Oncology.International journal of molecular sciences · 2025Review
- Blood collection tube and RNA purification method recommendations for extracellular RNA transcriptome profiling.Nature communications · 2025Article
- Recommended Clinical Context and Patient Context Data Elements for Liquid Biopsy Data Submitted to Data Repositories and Data Commons.Clinical and translational science · 2025Article
- Leptomeningeal metastatic disease: new frontiers and future directions.Nature reviews. Clinical oncology · 2025Review
- Multicentre analysis of nucleic acid quantification using aqueous humour liquid biopsy in uveal melanoma: implications for clinical testing.Canadian journal of ophthalmology. Journal canadien d'ophtalmologie · 2025Article
- Towards Preanalytical Best Practices for Liquid Biopsy Studies: A BLOODPAC Landscape Analysis.Clinical pharmacology and therapeutics · 2025Review
- Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and Stages.Diagnostics (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
50 authors.
Phillip G FebboIllumina, San Diego, California, USA.
Anne-Marie MartinNovartis Pharmaceuticals, East Hanover, New Jersey, USA.
Howard I ScherMemorial Sloan Kettering Cancer Center, New York, New York, USA.
J Carl BarrettAstraZeneca, Waltham, Massachusetts, USA.
Julia A BeaverCenter for Drug Evaluation and Research, US Food and Drug Administration, Silver Springs, Maryland, USA.
Paul J BeresfordBiodesix, Inc, Boulder, Colorado, USA.
Gideon M BlumenthalAstraZeneca, Waltham, Massachusetts, USA.
Kelli BramlettThermo Fisher Scientific, Austin, Texas, USA.
Carolyn ComptonCollege of American Pathologists, Scottsdale, Arizona, USA.
Ryan DittamoreEpic Sciences, San Diego, California, USA.
David A EberhardIllumina, San Diego, California, USA.
Daniel EdelsteinSysmex Inostics, Baltimore, Maryland, USA.
James GodseyIllumina, San Diego, California, USA.
Andrew GruenSeven Bridges Genomics, Boston, Massachusetts, USA.
Sean E HanlonOffice of the Director, National Cancer Institute, Bethesda, Maryland, USA.
James HicksUniversity of Southern California, Los Angeles, California, USA.
Daniel HovelsonUniversity of Michigan, Ann Arbor, Michigan, USA.
Melanie HullingsMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Donald JohannUniversity of Arkansas, Little Rock, Arkansas, USA.
Justin JohnsonAstraZeneca, Waltham, Massachusetts, USA.
Anand KolatkarUniversity of Southern California, Los Angeles, California, USA.
Peter KuhnUniversity of Southern California, Los Angeles, California, USA.
Rebecca LevineProstate Cancer Foundation, Los Angeles, California, USA.
Jean-Francois MartiniPfizer, San Diego, California, USA.
Daniel P MillerCenter for Translational Data Science, University of Chicago, Chicago, Illinois, USA.
Carissa MooreStreck, Inc., La Vista, Nebraska, USA.
Bryan MoySeven Bridges Genomics, Boston, Massachusetts, USA.
Anand PathakCenter for Device and Radiological Health, US Food and Drug Administration, Silver Springs, Maryland, USA.
Reena PhilipCenter for Device and Radiological Health, US Food and Drug Administration, Silver Springs, Maryland, USA.
David ReeseProvista Diagnostics Inc, New York, New York, USA.
Wendy RoyaltyStreck, Inc., La Vista, Nebraska, USA.
Matthew RyderSysmex Inostics, Baltimore, Maryland, USA.
Hakan SakulPfizer, San Diego, California, USA.
Lea M SalvatoreOpen Commons Consortium, Chicago, Illinois, USA.
Andrew SchadeEli Lilly and Company, Indianapolis, Indiana, USA.
Angela SilvestroNovartis Pharmaceuticals, Cambridge, Massachusetts, USA.
John K SimmonsPersonal Genome Diagnostics, Baltimore, Maryland, USA.
Jonathan SimonsProstate Cancer Foundation, Los Angeles, California, USA.
Seema Singh BhanFoundation Medicine, Cambridge, Massachusetts, USA.
Matthew D SmalleyCytoLumina, Inc, Los Angeles, California, USA.
Stella B SomiariCSSIMMW (Windber Research Institute), Windber, Pennsylvania, USA.
AmirAli TalasazGuardant Health, Inc, Redwood City, California, USA.
Muneesh TewariUniversity of Michigan, Ann Arbor, Michigan, USA.
Hsian-Rong TsengCytoLumina, Inc, Los Angeles, California, USA.
Jake VinsonProstate Cancer Clinical Trials Consortium, New York, New York, USA.
Walt WellsOpen Commons Consortium, Chicago, Illinois, USA.
Allison WelshFoundation Medicine, Cambridge, Massachusetts, USA.
Robert L GrossmanCenter for Translational Data Science, University of Chicago, Chicago, Illinois, USA.
Jerry S H LeeUniversity of Southern California, Los Angeles, California, USA.
Lauren C LeimanBloodPAC, Chicago, Illinois, USA.
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4MNCI NIH HHS P30 CA008748
Abstract
PubMed holds no abstract for this paper.
Indexed as
Databases, FactualLiquid BiopsyData ManagementHumansPublic-Private Sector Partnerships
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.